Clinical Progression Modes of Crizotinib Failure and Subsequent Management of Advanced Non‐Small Cell Lung Cancer With <i>ROS</i> 1 Rearrangement
The progression modes of ROS1 rearrangement may predict survival benefits and provide subsequent treatment strategies in ROS1-rearranged NSCLC.
Authors
- Jiao Yang
- Y. Chen
- Jin‐Ji Yang (ORCID: https://orcid.org/0000-0002-8498-0119)
- Junwei Su (ORCID: https://orcid.org/0000-0002-9664-362X)
- Ke‐Jun Liu
- Z. Mao
- Ming‐Ying Zheng
- Yu‐Er Gao
- Quan‐Quan Tan
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Third Affiliated Hospital of Southern Medical University (CN)
- Ezhou Central Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/cam4.71592
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Chinese Society of Clinical Oncology
- Guangdong Provincial People's Hospital